Fumimasa Kitamura

International Research Center of Medical Sciences (IRCMS) Kumamoto University

关注

立即认领

关注

立即认领

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 45 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Mesothelial Cells with Mesenchymal Features Enhance Peritoneal Dissemination by Forming a Protumorigenic Microenvironment

Atsuko Yonemura,Takashi Semba,Jun Zhang,Yibo Fan,Noriko Yasuda-Yoshihara,Huaitao Wang,Tomoyuki Uchihara,Tadahito Yasuda,Akiho Nishimura,Lingfeng Fu,Xichen Hu,Feng Wei,Fumimasa Kitamura,Takahiko Akiyama,Kohei Yamashita,Kojiro Eto,Shiro Iwagami,Masaaki Iwatsuki,Yuji Miyamoto,Keisuke Matsusaki,Juntaro Yamasaki,Osamu Nagano,Hideyuki Saya,Shumei Song,Patrick Tan,Hideo Baba,Jaffer A. Ajani,Takatsugu Ishimoto

CELL REPORTSno. 1 (2024)

引用0浏览0WOS引用

Figure S2 from Stromal Reprogramming Through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

Takahiko Akiyama,Tadahito Yasuda,Tomoyuki Uchihara,Noriko Yasuda-Yoshihara,Benjy J.Y. Tan,Atsuko Yonemura,Takashi Semba,Juntaro Yamasaki,Yoshihiro Komohara,Koji Ohnishi,Feng Wei,Lingfeng Fu,Jun Zhang,Fumimasa Kitamura,Kohei Yamashita,Kojiro Eto,Shiro Iwagami,Hirotake Tsukamoto,Terumasa Umemoto,Mari Masuda,Osamu Nagano,Yorifumi Satou,Hideyuki Saya,Patrick Tan,Hideo Baba,Takatsugu Ishimoto

crossref（2023）

引用0浏览0引用

Figure S9 from Stromal Reprogramming Through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

crossref（2023）

引用0浏览0引用

Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer

Fumimasa Kitamura,Takashi Semba,Noriko Yasuda-Yoshihara, Kosuke Yamada,Akiho Nishimura,Juntaro Yamasaki,Osamu Nagano,Tadahito Yasuda,Atsuko Yonemura,Yilin Tong,Huaitao Wang,Takahiko Akiyama,Kazuki Matsumura,Norio Uemura,Rumi Itoyama,Luke Bu,Lingfeng Fu,Xichen Hu,Feng Wei,Kosuke Mima,Katsunori Imai,Hiromitsu Hayashi,Yo-Ichi Yamashita,Yuji Miyamoto,Hideo Baba,Takatsugu Ishimoto

JCI insight（2023）

引用0浏览0WOS引用

Data from Stromal Reprogramming Through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

Takahiko Akiyama,Tadahito Yasuda,Tomoyuki Uchihara,Noriko Yasuda-Yoshihara,Benjy J. Y. Tan,Atsuko Yonemura,Takashi Semba,Juntaro Yamasaki,Yoshihiro Komohara,Koji Ohnishi,Feng Wei,Lingfeng Fu,Jun Zhang,Fumimasa Kitamura,Kohei Yamashita,Kojiro Eto,Shiro Iwagami,Hirotake Tsukamoto,Terumasa Umemoto,Mari Masuda,Osamu Nagano,Yorifumi Satou,Hideyuki Saya,Patrick Tan,Hideo Baba,Takatsugu Ishimoto

CANCER RESEARCH（2023）

引用7浏览0WOS引用

Mesothelial-Mesenchymal Transition Induced Mesothelial Cells Enhance Peritoneal Dissemination Through Forming Protumorigenic Microenvironment

Atsuko Yonemura,Takashi Semba,Jun Zhang,Noriko Yasuda-Yoshihara,Tomoyuki Uchihara,Tadahito Yasuda,Lingfeng Fu,Xichen Hu,Feng Wei,Fumimasa Kitamura,Takahiko Akiyama,Kohei Yamashita,Kojiro Eto,Shiro Iwagami,Keisuke Matsusaki,Juntaro Yamasaki,Osamu Nagano,Hideyuki Saya,SHUMEI SONG,Patrick Tan,Hideo Baba,Jaffer A. Ajani,Takatsugu Ishimoto

crossref（2023）

引用0浏览0引用

Figure S8 from Stromal Reprogramming Through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

crossref（2023）

引用0浏览0引用

Figure S7 from Stromal Reprogramming Through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

crossref（2023）

引用0浏览0引用

Figure S6 from Stromal Reprogramming Through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

crossref（2023）

引用0浏览0引用

Figure S5 from Stromal Reprogramming Through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

openalex（2023）

引用0浏览0引用

加载更多

作者统计

#Papers: 45

#Citation: 175

H-Index: 9

G-Index: 12

Sociability: 5

Diversity: 2

Activity: 28

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn